These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

579 related articles for article (PubMed ID: 28152201)

  • 1. Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI Position Paper.
    Shamji MH; Kappen JH; Akdis M; Jensen-Jarolim E; Knol EF; Kleine-Tebbe J; Bohle B; Chaker AM; Till SJ; Valenta R; Poulsen LK; Calderon MA; Demoly P; Pfaar O; Jacobsen L; Durham SR; Schmidt-Weber CB
    Allergy; 2017 Aug; 72(8):1156-1173. PubMed ID: 28152201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is it worthy to take full-course immunotherapy for allergic rhinitis? About efficacy biomarker of allergen immunotherapy.
    Wang W; Yin J
    Scand J Immunol; 2020 Jan; 91(1):e12817. PubMed ID: 31650620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allergen-specific immunotherapy for patients with atopic dermatitis sensitized to animal dander.
    Chu H; Park KH; Kim SM; Lee JH; Park JW; Lee KH; Park CO
    Immun Inflamm Dis; 2020 Jun; 8(2):165-169. PubMed ID: 32162849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allergen Immunotherapy: The Evidence Supporting the Efficacy and Safety of Subcutaneous Immunotherapy and Sublingual Forms of Immunotherapy for Allergic Rhinitis/Conjunctivitis and Asthma.
    Creticos PS; Gunaydin FE; Nolte H; Damask C; Durham SR
    J Allergy Clin Immunol Pract; 2024 Jun; 12(6):1415-1427. PubMed ID: 38685477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Functional IgE-Blocking Factor Induced by Allergen-Specific Immunotherapy Correlates with IgG4 Antibodies and a Decrease of Symptoms in House Dust Mite-Allergic Children.
    Zhao D; Lai X; Tian M; Jiang Y; Zheng Y; Gjesing B; Zhong N; Spangfort MD
    Int Arch Allergy Immunol; 2016; 169(2):113-20. PubMed ID: 27049773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific IgE and IgG4 Profiles of House Dust Mite Components in Allergen-Specific Immunotherapy.
    Yang L; Yang Y; Xu Q; Zhang W; Jiang Q; Li W; Wang Y; Ma D; Lin X; Sun B; Zhu R
    Front Immunol; 2021; 12():786738. PubMed ID: 35197963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does evidence support the use of cat allergen immunotherapy?
    Dhami S; Agarwal A
    Curr Opin Allergy Clin Immunol; 2018 Aug; 18(4):350-355. PubMed ID: 29870462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in Immunologic Indicators During Allergen-Specific Immunotherapy for Allergic Rhinitis and Determinants of Variability: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Jiang Z; Xiao H; Liu S; Meng J
    Am J Rhinol Allergy; 2021 Nov; 35(6):910-922. PubMed ID: 33631946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic alterations and efficacy of subcutaneous immunotherapy with Dermatophagoides pteronyssinus in monosensitized and polysensitized patients.
    Soyyigit S; Guloglu D; Ikinciogullari A; Secil D; Oztuna D; Mungan D; Misirligil Z; Sin BA
    Ann Allergy Asthma Immunol; 2016 Mar; 116(3):244-251.e2. PubMed ID: 26945497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of 2 months of allergen-specific immunotherapy with Bet v 1-derived contiguous overlapping peptides in patients with allergic rhinoconjunctivitis: Results of a phase IIb study.
    Spertini F; DellaCorte G; Kettner A; de Blay F; Jacobsen L; Jutel M; Worm M; Charlon V; Reymond C
    J Allergy Clin Immunol; 2016 Jul; 138(1):162-8. PubMed ID: 27373329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients.
    Rossi RE; Monasterolo G
    Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologic effects and tolerability profile of in-season initiation of a standardized-quality grass allergy immunotherapy tablet: a phase III, multicenter, randomized, double-blind, placebo-controlled trial in adults with grass pollen-induced rhinoconjunctivitis.
    Reich K; Gessner C; Kroker A; Schwab JA; Pohl W; Villesen H; Wüstenberg E; Emminger W
    Clin Ther; 2011 Jul; 33(7):828-40. PubMed ID: 21741092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper.
    Pfaar O; Demoly P; Gerth van Wijk R; Bonini S; Bousquet J; Canonica GW; Durham SR; Jacobsen L; Malling HJ; Mösges R; Papadopoulos NG; Rak S; Rodriguez del Rio P; Valovirta E; Wahn U; Calderon MA;
    Allergy; 2014 Jul; 69(7):854-67. PubMed ID: 24761804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salivary Immunoglobulin A, E, and G4 Levels Specific to Dermatophagoides pteronyssinus in Allergic Rhinitis Patients Treated With Subcutaneous Immunotherapy.
    Liu Y; Xing Z; Wang J; Geng C
    Am J Rhinol Allergy; 2018 Nov; 32(6):458-464. PubMed ID: 30124065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perspectives in allergen immunotherapy: 2019 and beyond.
    Pfaar O; Agache I; de Blay F; Bonini S; Chaker AM; Durham SR; Gawlik R; Hellings PW; Jutel M; Kleine-Tebbe J; Klimek L; Kopp MV; Nandy A; Rabin RL; van Ree R; Renz H; Roberts G; Salapatek AM; Schmidt-Weber CB; Shamji MH; Sturm GJ; Virchow JC; Wahn U; Willers C; Zieglmayer P; Akdis CA
    Allergy; 2019 Dec; 74 Suppl 108():3-25. PubMed ID: 31872476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Response to Subcutaneous Dermatophagoides pteronyssinus Immunotherapy in Children with Allergic Rhinitis and Asthma Is Independent of Sensitization to Blomia tropicalis Allergens.
    Chen S; Zheng Y; Chen B; Zhong H; Liao F; Wang L; Hui SF; Lai X
    Int Arch Allergy Immunol; 2019; 178(2):201-210. PubMed ID: 30544116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health economic analysis of allergen immunotherapy for the management of allergic rhinitis, asthma, food allergy and venom allergy: A systematic overview.
    Asaria M; Dhami S; van Ree R; Gerth van Wijk R; Muraro A; Roberts G; Sheikh A
    Allergy; 2018 Feb; 73(2):269-283. PubMed ID: 28718981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of allergen immunotherapy for inhaled allergens and predictive biomarkers.
    Shamji MH; Durham SR
    J Allergy Clin Immunol; 2017 Dec; 140(6):1485-1498. PubMed ID: 29221580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The practical role of serum allergen-specific IgE as potential biomarker for predicting responder to allergen immunotherapy.
    Ciprandi G; Tosca MA; Silvestri M
    Expert Rev Clin Immunol; 2014 Mar; 10(3):321-4. PubMed ID: 24450987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular allergen IgE tests show neosensitizaions occurring during house dust mite specific immunotherapy].
    Long Z; Zhang Q; Zou Z; Zheng Y; Chen J
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2024 Jul; 38(7):572-577. PubMed ID: 38973033
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 29.